Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: Optimal management of patients on antiplatelet therapy

References

• Karibe H, Kameyama M, Kawase M, et al. [Epidemiology of chronic subdural hematoma]. No Shinkei Geka 2011;39:1149–53 (Jpn).
   PubMedGoogle Scholar
• El-Kadi H, Miele VJ, Kaufman HH. Prognosis of chronic subdural hematomas. Neurosurg Clin N Am 2000;11:553–67.
   PubMed Web of Science ®Google Scholar
• Ernestus RI, Beldzinski P, Lanfermann H, Klug N. Chronic subdural hematoma: surgical treatment and outcome in 104 patients. Surg Neurol 1997;48:220–5.
   PubMedGoogle Scholar
• Markwalder TM. Chronic subdural hematomas: a review. J Neurosurg 1981;54:637–45.
   PubMed Web of Science ®Google Scholar
• Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 2001;95:256–62.
   PubMed Web of Science ®Google Scholar
• Torihashi K, Sadamasa N, Yoshida K, et al. Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 2008;63:1125–9; discussion 1129.
   PubMed Web of Science ®Google Scholar
• Wakai S, Hashimoto K, Watanabe N, et al. Efficacy of closed-system drainage in treating chronic subdural hematoma: a prospective comparative study. Neurosurgery 1990;26:771–3.
   PubMed Web of Science ®Google Scholar
• Abouzari M, Rashidi A, Rezaii J, et al. The role of postoperative patient posture in the recurrence of traumatic chronic subdural hematoma after burr-hole surgery. Neurosurgery 2007;61:794–7; discussion 797.
   PubMed Web of Science ®Google Scholar
• Asano Y, Hasuo M, Takahashi I, Shimosawa S. [Recurrent cases of chronic subdural hematoma–its clinical review and serial CT findings]. No To Shinkei 1992;44:827–31 (Jpn).
   PubMedGoogle Scholar
• Forster MT, Mathé AK, Senft C, et al. The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma. J Clin Neurosci 2010; 17:975–9.
   PubMed Web of Science ®Google Scholar
• Fukuhara T, Gotoh M, Asari S, Ohmoto T, Akioka T. The relationship between brain surface elastance and brain reexpansion after evacuation of chronic subdural hematoma. Surg Neurol 1996; 45:570–4.
   PubMedGoogle Scholar
• Ko BS, Lee JK, Seo BR, et al. Clinical analysis of risk factors related to recurrent chronic subdural hematoma. J Korean Neurosurg Soc 2008;43:11–15.
   PubMed Web of Science ®Google Scholar
• Lindvall P, Koskinen LO. Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 2009;16:1287–1290.
   PubMed Web of Science ®Google Scholar
• Mori K, Maeda M. Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 2001;41:371–81.
   PubMed Web of Science ®Google Scholar
• Nakaguchi H, Tanishima T, Yoshimasu N. Relationship between drainage catheter location and postoperative recurrence of chronic subdural hematoma after burr-hole irrigation and closed-system drainage. J Neurosurg 2000;93:791–5.
   PubMed Web of Science ®Google Scholar
• Oishi M, Toyama M, Tamatani S, Kitazawa T, Saito M. Clinical factors of recurrent chronic subdural hematoma. Neurol Med Chir (Tokyo) 2001;41:382–6.
   PubMedGoogle Scholar
• Yamamoto H, Hirashima Y, Hamada H, et al. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 2003;98:1217–21.
   PubMed Web of Science ®Google Scholar
• Baechli H, Nordmann A, Bucher HC, Gratzl O. Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 2004;27:263–6.
   PubMed Web of Science ®Google Scholar
• Sim Y-W, Min K-S, Lee M-S, Kim Y-G, Kim D-H. Recent changes in risk factors of chronic subdural hematoma. J Korean Neurosurg Soc 2012;52:234–39.
   PubMed Web of Science ®Google Scholar
• Palinski W. New evidence for beneficial effects of statins unrelated to lipid lowering. Arterioscler Thromb Vasc Biol 2001;21:3–5.
   PubMed Web of Science ®Google Scholar
• Tapia-Péez JH, Sanchez-Aguilar M, Schneider T. The role of statins in neurosurgery. Neurosurg Rev 2010;33:259–70; discussion 270.
   PubMedGoogle Scholar
• Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 2008;14:37–44.
   PubMed Web of Science ®Google Scholar
• Berghauser Pont LM, Dammers R, Schouten JW, Lingsma HF, Dirven CM. Clinical factors associated with outcome in chronic subdural hematoma: a retrospective cohort study of patients on pre-operative corticosteroid therapy. Neurosurgery 2011;
   Google Scholar
• Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 2004;100:24–32.
   PubMed Web of Science ®Google Scholar
• Hong HJ, Kim YJ, Yi HJ, et al. Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol 2009;71:161–5; discussion 165–6.
   PubMedGoogle Scholar
• Stanisic M, Lyngstadaas SP, Pripp AH, et al. Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study. Acta Neurochir (Wien) 2012;154:113–20.
   PubMed Web of Science ®Google Scholar
• Weigel R, Hohenstein A, Schlickum L, Weiss C, Schilling L. Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism. Neurosurgery 2007;61:788–92; discussion 792–3.
   PubMed Web of Science ®Google Scholar